Atlas Trials

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Clinical trial NCT02395666 · COMPLETED

Trial details

NCT number
NCT02395666
Sponsor
Giselle Sholler
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2015-03-05
Primary completion
2018-03-27
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.